Human farnesyl pyrophosphate synthase (hFPPS) is a wellsettled therapeutic target and it is an enzyme of the mevalonate pathway which catalyzes the biosynthesis of the C-15 isoprenoid farnesyl pyrophosphate. QSAR studies by using Monte Carlo method for human farnesyl pyrophosphate synthase inhibitors has been carried out using balance of correlation technique with Index of ideality correlation. For construction of QSAR models, six random splits were prepared from the data of 73 phosphonates and hybrid optimal descriptors procured from graph (HFG) and SMILES based notations were employed. The developed QSAR models have robustness, good fitting ability, generalizability and internal predictive ability. The external predictive ability has been certified by testing various precedents. The values of R 2 , IIC, Q 2 and ∆R 2 m for the best model are 0.9304, 0.9614, 0.9061 and 0.0861 respectively. The developed QSAR models met with the specified standards given in OECD guideline and applicability domain. The structural feature promoters for the end point increase and promoters for end point decrease have been extracted. The predicted pIC 50 for the new proposed compounds have also been reported.
Introduction
For the drug development, farnesyl pyrophosphate synthase (FPPS) enzyme has been established as a molecular target [1] . FPPS (EC 2.5.1.10), a member of E-family of the prenyltransferases, is an important enzyme in the mevalonate pathway, the elite method of isoprenoid synthesis in animals, concerned with cholesterol biosynthesis and post-translational modification of signaling proteins [2] [3] [4] . The human farnesyl pyrophosphate synthase (hFPPS) catalyzes the biosynthesis of the C-15 isoprenoid farnesyl pyrophosphate (FPP) from dimethylallyl pyrophosphate (DMAPP) through geranyl pyrophosphate (GPP) via one by one abridgment of two isopentenyl pyrophosphate (IPP) units [5] . FPP and GGPP play an imperative function in a surfeit of cellular biological functions such as over expression of FPPS in fibroblasts also increases farnesylation of Ras signaling protein and activates the extracellular Ras/ERK signaling cascade [6] . Bisphosphonates, the stable analogues of inorganic pyrophosphate, are a class of drugs that have been used to treat several bone disease such as osteoporosis, post menopausal osteoporosis in elderly women, osteitis, Paget's disease of bone, multiple myeloma, osteogenesis imperfecta and similar diseases [7] . Literature survey reveals that N-containing bisphosphonates (NBps) target FPPS enzyme of the mevalonate pathway [8] . Many NBps drugs like alendronate, risedronate and pamidronate have been revealed to inhibit FPPS enzyme [9] [10] [11] .
Recently, J. Park et al. [12] discovered the biological importance of the allosteric pocket, near the IPP substrate binding site of the hFPPS active site, and exhibited that FPP product can bind to this allosteric pocket. This binding sealed the enzyme in an inactive conformation and therefore, suppling a feedback mechanism for regulating the intra-cellular levels of isoprenoid biosynthesis in vivo. To understand this mechanism, the thienopyrimidine-based monophosphonate (ThP-MP) or N-containing monophosphonates (NMps) have been designed and reported by J. Park et al. [1, 3] to get the essential minimal pharmacophore that is required for allosteric inhibition of hFPPS.
Therefore, many scientists are engaged to find out the liaison between the structure and the inhibition activities of phosphonate inhibitors [13] [14] [15] [16] . The most successful method for constructing this liaison is Quantitative Structure Activity Relationship (QSAR) method, which is used to predict the drug activities and information for designing new potential drugs [17] [18] [19] [20] [21] . In the present era of drug design, the significance of quantitative structure activity relationship method is well recognized in view of the fact that QSAR know how to build the early forecast of activity-related characteristics of drug molecules and can eradicate the molecules with obnoxious properties [22, 23] . Literature survey shows that 3D-QSAR studies have been reported between NBPs and FPPS [24] [25] [26] [27] [28] [29] [30] [31] . However, the majority of QSAR study was performed in non-mammalian species although Fernández et al. [32] and Liu et al. [33] reported the 3D-QSAR of N-BPs against hFPPS. It should be more reliab l e t o t a k e i n t o a c c o u n t t h i e n o p y r i m i d i n e -b a s e d monophosphonate (ThP-MP) and N-BPs to study the QSAR of phosphonate.
Recent published papers reveal that the simplified molecular input line entry system (SMILES) is a substitute to classical QSAR methods and it can be used for the prediction of molecular structures with appropriate end point or activity [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] . In all the QSAR models, depending on Monte Carlo optimization method, the pertinent activity is treated as random event [50] [51] [52] [53] . In the light of these facts and in continuation of our work [48, [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] on biological important heterocyclic compounds, we herein report Monte Carlo method based QSAR studies of 73 compounds i. e. thienopyrimidine-based monophosphonate (ThP-MP) and N-containing bisphosphonates N-BPs active against hFPPS using SMILES and graph optimal descriptors.
Method
The data set A series of 73 phosphonate (NBPs and NMPs) derivatives with activity as hfpps inhibitors was retrieved from literature [3, 32, 33] . The structures of NBPs and NMPs were sketched using Marvin sketch [Marvin Sketch 6.0.4 Chem Axon Ltd. http://www.chemaxon.com] and converted into SMILES by OpenBabel [64] . The SMILES notations of NBPs and ThP-MP molecules are presented in table 1S (supplementary information). The QSAR models were built up for six random splits (20-30 % of compounds were used in calibration set). All six splits were designed according to the following principles: i) the range of the endpoint (pIC 50 ) is evenly distributed for each subset ii) the total level of identity between all the splits is not more than 40 % which shows that splits are different (table 2S, supplementary information).
The identity percentage of the six splits has been confirmed by the reported method [65] . Four sets namely training, invisible-training, calibration, and validation sets were made from all the six splits. Each set has its sole responsibility. The roll of the different sets for developing a QSAR model are: (a) The training set (Train) is designer of the model; (ii) invisible-training (invTrain) set is surveyor of the model, this set sense and prevent the process of overtraining; (iii) the calibration set (Calib) is a specialist and have the authority to declare that the model is ready; (iv) the validation set (Vali) is the reviewer of actual predictive potential of the model.
Index of ideality of correlation (IIC) used to build up predictive model
The balance of correlations is a technique described in the literature [66] [67] [68] [69] . The crux of this technique is building up of a model via the Monte Carlo optimization of the following target function (TF):
The R training and R invisible − training are correlation coefficients between observed and calculated values of an endpoint for the training and invisible training sets, respectively. The Const is an empirical constant which is usually fixed [69] .
In the present manuscript, modified target function (TF m ) for the balance of correlation has been used:
The index of ideality of correlation (IIC) can be an alternative of traditional correlation coefficient [66, 67] . Literature survey shows that a QSPR/QSAR model without IIC for the prediction of endpoint has some possible defects of error [68, 69] .
The index of ideality of correlation (IIC) is calculated with the following formula:
The r calibration is the correlation coefficient value between experimental and calculated values of an endpoint for the calibration set. MAE is mean absolute error which can be determined with the following equation:
N is the number of 0
The quality of prediction (Δ k ) for one substance from a set can be estimated as the following:
The optimal descriptor
Descriptors procured from either SMILES or molecular graph can be applied to symbolize the molecular structure. Literature survey reveals that "hybrid" demonstration of the molecular structure, i. e., by SMILES along with molecular graph, can grant a better model demonstrated by higher statistical quality than the model which is predicted by only SMILES or molecular graph [48] , [70] . The hybrid optimal descriptor DCW, adopted for generating QSAR models for the pIC50, was determined as per the following equation:
Where T is threshold and N epoch is number of epochs used in monte carlo method optimization. Threshold helps in exclusion of use of rare molecular features. SMILES based descriptors were calculated using following equation: 
Where, S k , SS k and SSS k represents local smile attributes while BOND, NOSP, HALO, HARD and PAIR represent global SMILES attributes and exhibit presence of double, triple or stereochemical bond, presence of nitrogen, oxygen, sulphur and phosphorus, presence of halogen as well as pairing between these attributes [71] .
Optimal descriptors based on graph were calculated using following equation:
Where, EC0 k , EC1 k , EC2 k are Morgan's extended connectivity indices for k th vertex respectively. VS2 k is the sum of vertex degrees which take place at topological distance 2 relative to k th vertex. NNC is the nearest neighbor code. The C3, C4, C5 and C6 are descriptors for presence of three-member (C3), four-member (C4), five-member (C5) and six-member rings (C6) respectively. In this study, hydrogen filled graphs (HFG) have been used.
CORALSEA software was used to prepare the QSAR models. The best model was scrutinized using the procedure given in literature 70 
Validation of QSAR model
The most important objective of any QSAR modeling is to establish a sturdy model competent to predict the idiosyncrasy of new molecules in an objective, reliable and precise manner [49, 72] . Three methods are cited in the literature for evaluation of sturdiness and reliability of developed model. These are: (a) internal validation or cross-validation using the training set compounds (b) external validation using the test set compounds (c) data randomization or Y-scrambling.
Leave-one-out (LOO) cross validation technique was used to develop models as an internal validation. Cross-validated Q 2 interpret the predictive ability of the model [73, 74] . Higher the value of Q 2 means better model prediction. The cross-validated Q 2 is stated as:
Where, Y obs is observed property of the training set compounds, Y pred is LOO-predicted property of the training set compounds and is mean observed property of the training set compounds. The predictive ability of model is considered as acceptable when Q 2 is greater than 0.5. Similar methodology can be applied for external validation. The predictive ability of a model is determined by calculating Q 2 ext which is defined as:
Where, Y obs(test) is the observed property of the test set compounds, Y pred(test) is the predicted property of the test set compounds and Y ̅ train is mean observed property of the training set compounds. The value Q 2 ext for an acceptable model should be greater than 0.5 test [75] .
Y-randomization test was performed to inspect the robustness of the model. A parameter C R 2 p penalizes the model R 2 for a small difference between squared mean correlation coefficient (R 2 r) of randomized models and squared correlation coefficient (R 2 ) of the non-randomized model [75] . The parameter C R 2 p is defined as:
For an acceptable QSAR model, the value of C R 2 p should be greater than 0.5.
Compliance with Applicability domain (AD) and OECD principles
Applicability domain (AD) is another important aspect of a built QSAR model. It gives the information related to the biological, structure and physiochemical properties to make the prophecy for new compounds. AD is especially significant because it is applied for the evaluation of the authenticity of the developed QSAR model. Compounds from the training set can be used to interpret the AD of the developed QSPR model. The predictions of a QSAR/QSPR model are more authentic when predicted molecules are within applicability. For defining AD, procedure reported in literature was applied [65] .
To assist the reflection of a QSAR model for regulatory purposes [76] , it should satisfy the five principal as: 1) a defined endpoint: hFPPS inhibitory activity as definite endpoint, 2) an unambiguous algorithm: Monte Carlo method as unambiguous algorithm, 3) a defined domain of applicability: percentage of molecular features with defined role as domain of applicability, 4) appropriate measures of goodness-of-fit, robustness and predictivity: High values of R 2 , Q 2 ; C R 2 p , R 2 m (av) and ∆R 2 m metrics, as suitable measures of goodness-of-fit, robustness and predictivity 5) a mechanistic interpretation, if possible: List of molecular features responsible for increase and decrease of activity are applied for mechanistic interpretation.
Result and Discussion
Six random splits were generated from the data set presented in table 1S (supplementary information). All sets were carefully prepared so the ranges are approximately equivalent for each sub-set. The hybrid optimal descriptor DCW was adopted for generating QSAR models. The outcomes of the applied methodology for defining AD reveal that maximum numbers of molecules are within the defined AD. So, all the studied compounds had typical behavior and all were incorporated in developing QSAR models.
The best QSAR models for six different splits with other statistical parameters of all six equations are given in ▶table 1.
The statistical parameters given in ▶table 1 clearly indicate that the values of statistical criteria of all six equations are significant for each subset i. e. training, invisible-training, calibration and va-lidation sets. The statistical trait of calibration set (R 2 = 0.9304 and Q 2 = 0.9061) for the equation of split 4 was distinguished best, therefore the QSAR model expressed by this was judged to be the preeminent model. The good fitting ability and good internal predictive power of the described model has been implied by the R 2 value (0.7380) for the training sets and Q 2 value of calibration set. The value of R 2 is 0.7602 for validation sets which shows the excellent external predictive ability of the developed QSAR model. The authenticity and robustness of the QSAR models are justified by less difference between R 2 and Q 2 values. Y-randomization process was applied to check the chance correlation, in which Y values were scrambled in 1000 trials in ten separate runs (table 3S, supplementary information). The resulting value of C R 2 p was found more than 0.5 which authenticate that the developed models are free from chance correlation [75] . The built QSAR model was checked for the external predictive power by applying the benchmarks proposed by Golbraikh and Tropsha [74] , Roy and Roy [77] and Ojha et al. [78] . The values of different proposed benchmarks are displayed in table 4S (supplementary information) and it can be seen that these values are within specified ranges. Therefore, it can be said that these QSAR equations have good external predictive ability. Calculated activity and applicability domain of all compounds along with different sets are exhibited in supplementary table 5S (supplementary information). The procedure described in literature was used for the calculation of applicability domain and it is based on split defect [66] .
The plots between observed versus calculated activity and residuals versus observed activity are shown in ▶Fig. 1.
Mechanistic interpretation of developed QSAR models
The correlation weights (CW) of structural features (SAk) give the information about the structural attributes which are responsible for the increase and decrease of the endpoint. If CW(SAk) is positive in all three probes then this feature will enhance the value of endpoint and if CW(SAk) is negative in all three probes then it will reduce the value of endpoint. Based on these considerations, some graph based structural attributes with stable positive values (pIC50 enhancer) for best QSAR model 3 are EC0-O…1…, EC0-P…4…, EC1-O…4…, NNC-O…101., EC1-C…5…, NNC-P…413, EC2-C…10.., VS2-C…6… etc. Similarly, some graph based structural attributes with stable negative values (pIC50 decreasing) for this model are EC0-C…2…, EC1-C…4…, EC0-C…3…, EC0-N…2…, EC1-C…6…, NNC-C… 220., VS2-C…9… etc.
In the same manner, some pIC50 enhancer SMILES based attribu- The structure generated using the promoters of increase in end point with their predicted pIC50 are given in table 6S (supplementary information). By using the promoters of endpoint, we have developed some more hFPPS inhibitors. We have predicted the pIC 50 by all QSAR models using their respective equation and then average pIC50 was calculated. On the basis of average calculated pIC50, compound 14 was found most potent by using model of split 3 but the difference between the maximum and minimum calculated pIC50 from all models is 3.8938. Compound 16 shows nearly constant value of calculated pIC50 and the difference between the maximum and minimum calculated pIC50 is 0.9059. The graphical representation of all the calculated pIC50 with average calculated pIC50 is shown in ▶Fig. 2. The result of table 6S (supplementary information) clearly shows that the bisphosphonates developed as hFPPS inhibitors are more potent inhibitors than monophosphonates. It has been reported in literature [1, 3, [7] [8] [9] [10] [11] [12] that the interactions of the bisphosphonates in the active site of the HFFPS are highly conditioned by the protonation state of the functional groups but the method used in this work does not consider this aspect. It is a limitation of this work. Despite that the proposed QSAR models predicted the activity of reported bisphosphonates and monophosphonates accurately.
Two 3D QSAR model developed by comparative molecular field analysis (CoMFA) method for the some part of our dataset has been described by Fernández et al. [32] and Liu et al. [33] . The values for statistical features used by Fernández et al. [32] to examine the model were n = 20, R 2 = 0.943, Q 2 = 0.586, F = 63 and SEE = 0.11 and by Liu et al. [33] to examine the model were n (training) = 42, R 2 (training) = 0.975, n (test) = 11 and R 2 (test) = 0.0.753. In the reported QSAR models, monophosphonates were not used, but have used to develop a relationship between monophosphonate and bisphosphonates. So, we can say that the developed QSAR models in the present manuscript have better statistical quality as compared to the reported model in terms of internal as well as external prediction criteria. Also, the resent QSAR models are one parameter 2D QSAR models which are simple in interpretation and simple to apply. Where, n is number of cases, R 2 is the squared correlation coefficient, CCC is concordance correlation coefficient, IIC is Index of ideality of correlation, Q 2 is the leave-one-out (LOO) cross-validation coefficient, s is standard error of estimation, MAE is mean average error, F is the Fischer ratio and NC means not calculated.
Conclusion
Monte carlo optimization method using CORAL software has been used successfully for designing a statistically robust QSAR models for human farnesyl pyrophosphate synthase inhibitors. The best QSAR model described by DCW (7, 13) optimal descriptor was obtained from split 4. In the mechanistic interpretation, the presence of nitrogen with double bond, a phosphate group and oxygen with branched double bond were found promoter of endpoint. The dis-▶Fig. 1 The plots between observed pIC50 versus calculated pIC50 and residuals versus observed pIC50.
▶Fig. 2 Graphical representation of calculated pIC50 from all models for all proposed compound.
cussed QSAR models satisfy the OECD conditions for a good QSAR model. The outcomes of the applied methodology for defining AD reveal that maximum numbers of molecules are within the defined AD. Thus, this approach can be used for generation of new potential human farnesyl pyrophosphate synthase inhibitors.
